Description

NSE notifies the listing of 19,740 partly paid-up equity shares of Solara Active Pharma Sciences Limited with effect from January 30, 2026.

Summary

National Stock Exchange of India has admitted 19,740 partly paid-up equity shares of Solara Active Pharma Sciences Limited for trading on the Capital Market segment. The shares have a face value of Rs. 10/- each with Rs. 7/- paid up and will trade under the symbol SOLARAPP1 with ISIN IN9624Z01022. Trading will commence from January 30, 2026.

Key Points

  • 19,740 partly paid-up equity shares admitted to trading
  • Symbol: SOLARAPP1
  • ISIN Code: IN9624Z01022
  • Face Value: Rs. 10/- per share (Rs. 7/- paid up)
  • Market Lot: 1 share
  • No lock-in period applicable
  • Shares currently held under temporary ISIN IN8624Z01031 in dematerialized mode

Share Distribution Details

  • Distinctive Numbers Range 1: 46012206 to 46020701 (8,496 shares)
  • Distinctive Numbers Range 2: 47621509 to 47632539 (11,031 shares)
  • Distinctive Numbers Range 3: 47766601 to 47766813 (213 shares)
  • Total: 19,740 shares

Regulatory Framework

  • Issued under Regulation 3.1.1 of NSE (Capital Market) Trading Regulations Part A
  • Lot size specified under Regulation 2.5.5 of NSE (Capital Market) Trading Regulations Part A
  • Temporary ISIN arrangement follows SEBI circulars CIR/MRD/DP/21/2012 (August 02, 2012) and CIR/MRD/DP/24/2012 (September 11, 2012) for additional issue of securities

Important Dates

  • Circular Date: January 29, 2026
  • Effective Trading Date: January 30, 2026

Impact Assessment

This is a routine listing of partly paid-up equity shares representing an additional issuance by Solara Active Pharma Sciences Limited. The relatively small number of shares (19,740) suggests limited immediate market impact. The shares will trade under a separate symbol (SOLARAPP1) to distinguish them from fully paid-up shares, allowing investors to identify and trade these securities appropriately.

Impact Justification

Routine listing of a small number of partly paid-up shares for an existing listed company with limited market-wide impact